Icu Mortality Articles & Analysis: Older
3 news found
ECMO (ExtraCorporeal Membrane Oxygenation) centers who received ECMO plus CytoSorb therapy for life-threatening refractory respiratory failure under FDA EUA between April 2020 and April 2021.1 As highlighted in topline results that were previously presented at the 40th International Symposium on Intensive Care and Emergency Medicine (ISICEM 2021) conference in September, the primary outcome of ...
” Prior data in the area of Surgical ICU Management showed a similarly high level of BVA-100 tests resulting in a change of treatment strategy. In a randomized control trial (RCT) published in the journal Shock, the BVA-100 test has shown to reduce ICU mortality by 66% (P=0.03) and reduce ventilator days in patients suffering ...
Bacterial infections are a major source of mortality among ICU patients. According to recently published reports, the mortality in COVID-19 patients requiring advanced respiratory support (ventilators) ranges from 66% to 86%. N8 Medical believes that use of the CeraShield™Endotracheal Tube may reduce this rate of mortality. ...